Formulary Search
A to Z of Drugs : I
Records returned : 100 (on 29 May 2025 at 00:22:58).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
50mg tablets for bone metastases in breast cancer. Specialist initiation and prescribing for at least 1 month before any request is made for primary care prescribing.
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Used in
- hypercalcaemia of malignancy
- bone metastases
- prevention of skeletal events
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
150mg tablets
(note - 50mg tablets are not licensed for this indication)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Paediatric consultants only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
Preferred
5% gel. This is the least costly option for primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Restricted for patients where an oral NSAID is not suitable.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
Restrictions / Comments:
Important
Reserved for patients with swallowing difficulties
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted for patients where an oral NSAID is not suitable
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Modified release capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
RSFT only - NHSE commissioned
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
With statin therapy in patients with raised triglycerides
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
Dabigatran anticoagulant reversal.
RESTRICTED to Haematologists only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NHSE Specialised Commissioned Services only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Specialist Centres only. Not a service that is provided by any of the Surrey Heartlands Acute Trusts.
NHS England specialist centres only. Not a service that is provided by any of the Surrey Heartlands Acute Trusts
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Indication: in transit metastases from melanoma
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Prescribing in secondary care is commissioned by NHSE - Blueteq forms are required.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (dry powder)
Restrictions / Comments:
Important
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
- Tablets
Restrictions / Comments:
Important
Preferred
Preferred thiazide diuretic
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
For use in endoscopic procedures.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Paediatric consultants only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Capsules (slow release)
Restrictions / Comments:
Important
Only for use in gout.
ASPH restricted to rheumatology only.
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Liquid
Restrictions / Comments:
Important
Prescribe 125ml or 200ml. Care should be taken to ensure correct presentation is prescribed – avoid 500ml presentations
2nd line High Energy Formula
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Liquid
Restrictions / Comments:
Important
Prescribe as 200ml
3rd line High Energy Formula
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
For use in ankylosing spondylitis only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Highly specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
For UC & CD. Prescribe by brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Commissioned - Specilaist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Specialist Commissioned services only. Not routinely commissioned.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form.
SASH - restricted to diabetes team initiation only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Biosimilar insulin aspart (Trurapi) should be used in preference to NovoRapid.
Prescribe by brand and state form.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Preferred
Prescribe by brand and state form. Lower-cost biosimilar. Preferred for new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
Restrictions / Comments:
Important
Initiation by Diabetes team only. Prescribe by brand.
Insulin degludec is available in strengths of 100units/mL and 200units/mL - ensure correct strength is prescribed and dispensed
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
Restrictions / Comments:
Important
Levemir (insulin detemir Penfill / FlexPen) is being discontinued. Supplies are expected to run out by Dec 2026. It is recommended that this is not initiated in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
Restrictions / Comments:
Important
Prescribe by brand and state form. Semglee (biosimilar) is a lower cost option for patients using a pre-filled pen.
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form. Semglee (biosimilar) is a lower cost option for patients using a pre-filled pen. Lantus remains an option in existing patients and those preferring a reusable pen.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pre-filled pen
Restrictions / Comments:
Important
Preferred
Semglee (biosimilar insulin glargine) is the preferred brand for all new patients who require a pre-filled pen.
Prescribe by brand.
Note - Semglee is NOT available as cartridges for use in re-usable insulin pens.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pre-filled pen
Restrictions / Comments:
Important
Initiation by diabetes consultants or GPs with a specialist interest in diabetes. For use in poorly controlled patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form.
SASH - restricted to diabetes team initiation only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Biosimilar insulin Lispro (Admelog).
Prescribe by brand and state form.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form. Admelog (biosimilar insulin lispro) is lower cost and should be considered in preference to Humalog.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Preferred
https://www.toxbase.org/ . Intralipid 20%. Off-label use
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Topical solution
Restrictions / Comments:
Formulary Status :
Links :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
For patients unable to take tablets.
Iodine 5%, potassium iodide 10% (130mg/ml iodine)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (Metered Dose)
Restrictions / Comments:
Important
No added benefit in patient's on LAMA.
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (Metered Dose)
Restrictions / Comments:
Important
Specialist paediatric recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nebules
Restrictions / Comments:
Important
Specialist recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nebules
Restrictions / Comments:
Important
Specialist recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nasal spray
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nasal spray
- Sublingual spray
Restrictions / Comments:
Important
Nasal spray applied sublingually. Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (Metered Dose)
- Sublingual spray
Restrictions / Comments:
Important
Metered dose inhaler applied sublingually. Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nebules
Restrictions / Comments:
Important
Specialist recommendation following patient initiation and education on nebuliser therapy
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
Ferric derisomaltose is preferred.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
Ferric derisomaltose is preferred.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation and stabilisation by specialist for a minimum of 6 months before transfer of prescribing to primary care.
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Vials
Restrictions / Comments:
Important
Initiation by diabetes team only. Usage is low but available for existing patients
Links :
Indication :
Status :
Formulations :
- Cartridges
- Pre-filled pen
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Vials
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cartridges
- Vials
Restrictions / Comments:
Important
Prescribe by brand and state form.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Twice daily (assymetric) dosing is recommended
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
- Modified release tablets
Restrictions / Comments:
Important
Restricted to when isosorbide mononitrate standard release is not suitable.
Primary Care prescribers should follow local advice on the most cost-effective brands. OptimiseRx will be used to identify current recommendations.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (granules)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
Restrictions / Comments:
Important
Ituluzax (birch pollen) - RSFT Immunology only. Approved for over 18s only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted to cardiology. Specialist initiation and at least one month supply before transfer to primary care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted to initiation by cardiology only. Transfer of prescribing to primary care only after initiation and at least the first month supply from the specialist.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Specialist Commissioned Services only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Specialist Commissioned Services only
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :